RPRXRoyalty PharmaHealth Care
$56.93EarningsNov 4, 2026
1D—1W—1M—3M—1Y—
Market cap$31.7BCompany infoRevenue$2.5B52-wk range$35 – $64IndustryBiotechnologyWebsiteroyaltypharma.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +61.5% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E32.7×2943
11
151
P / S12.5×69
7
12
P / FCF10.7×7890
5
13
EV / EBITDA23.2×2032
12
60
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin89.4%9795
89%
100%
Operating margin62.3%98100
14%
84%
Net margin32.1%9396
2%
51%
ROE12.4%4556
1%
19%
ROIC9.5%5152
2%
13%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity1.312516
0.9
1.4
Net debt / EBITDA4.7×159
Current ratio1.294723
Interest coverage4.4×4034
Per shareTTM, with year-over-year change
Revenue / share$4.55▲ +10%
EPS (diluted)$1.74▼ −19%
FCF / share$5.34▲ +24%
Est. EPS growth (fwd)—